People didn't have to wait long after transcatheter aortic valve replacement (TAVR or TAVI) to safely undergo noncardiac surgery, though suboptimal device performance should give pause for another ...

In the United States, cardiovascular health is especially important. Heart disease is the leading cause of death in the U.S., and as many as 1.5 million people have been diagnosed with aortic stenosis ...

The novel findings, published today in the peer-reviewed journal The Lancet, are significant because recent randomized clinical trials have shown that TAVR is a meaningful treatment option for both ...

Transcatheter aortic valve replacement, or TAVR, is a minimally invasive heart procedure that replaces a thickened aortic valve that can't fully open (aortic stenosis). The procedure restores proper ...

A transcatheter aortic valve replacement (TAVR) therapy was approved by the US Food and Drug Administration (FDA) for patients with severe aortic stenosis even without symptoms. This is the first FDA ...

An Oct. 21 study in Circulation: Cardiovascular Quality and Outcomes found that most transcatheter aortic valve replacement programs are found in affluent metropolitan areas. Researchers identified ...

Early transcatheter aortic valve replacement bests clinical surveillance for reducing death, stroke, unplanned hospitalization. HealthDay News — Early transcatheter aortic valve replacement (TAVR) is ...

Please provide your email address to receive an email when new articles are posted on . TAVR was superior to clinical surveillance in patients with asymptomatic severe aortic stenosis. Almost all ...

The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is more ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Newer ...